Loading…
Loading…
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Investigators report dramatic gains in what they uncover using Agentic AI vs. manual review; the Autumn 2026 Release brings expanded device and operating system access TYSONS CORNER, Va.
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
/PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), leader mondial des solutions numériques d'investigation et de renseignement basées sur l'IA pour les
TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Oct. 20, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its third-quarter 2026 financial results before the U.S. markets open on Thursday, November 12, 2026.
Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) CFO David Barter sold 12,134 shares of Cellebrite DI stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $11.21, for a total transaction of $136,022.14. Following the transaction, the chief financial officer directly owned 322,085 shares in
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors Cellebrite DI Ltd. (“Cellebrite” or the “Company”) (NASDAQ: CLBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.